Urology News: Breaking Urology News, Comments and Articles. - Page: 5

EHR improves coordination of care in hematuria work-up

(HealthDay)—Care coordination, enhanced using an electronic health record system, can reduce the number of health care visits needed for the work-up of hematuria, according to a study published in the July issue of The Journal of Urology.

Google+ Hangout Discussion Today With Prostate Specialist, Mark Scholz, MD and Wirebuzz.com for International Men's Health Month

MARINA DEL REY, Calif., June 14, 2013 /PRNewswire/ -- Google, in partnership with WireBuzz.com and Prevention.com, will feature a series of health-centered Google+ Hangouts for International Men's Health Month. The live discussions will build awareness around men's health issues including diet and exercise, cancer, sexual health and more. Using Google+ Hangouts, participants from all over th...

Baron and Budd Now Handling Actos Lawsuits

Alert: Diabetes Drug Actos Has Allegedly Been Linked to Serious Health Problems, Including Bladder Cancer DALLAS (PRWEB) June 14, 2013 National plaintiffs’ law firm Baron and Budd is now handling lawsuits regarding the alleged adverse side effects of the diabetes drug Actos. Actos, also known as pioglitazone, has been prescribed since 1999 to help treat type 2 diabetes. The drug was marketed to...

Texas Children's Hospital opens first pediatric Stone Clinic in Texas

HOUSTON, June 14, 2013 /PRNewswire-USNewswire/ -- Texas Children's Hospital announced a new, first of its kind in Texas, pediatric Stone Clinic which will provide comprehensive care for children and adolescents with kidney stones. The clinic will be comprised of a multidisciplinary team of specialists that will evaluate, diagnose and treat children who have previously had kidney stones, as well as...

Research reprograms future of kidney health

University of Queensland researchers have reprogrammed adult kidney cells to act as stem cells to repair damaged kidneys.

Chesapeake Urology Physicians Inducted into Healing Hands Guild

OWINGS MILLS, Md., June 13, 2013 /PRNewswire/ -- Chesapeake Urology Associates, PA, the premier urology practice in Maryland and the Mid-Atlantic region, is pleased to announce that two of its physicians were honored by the University of Maryland St. Joseph Medical Center and inducted into its Healing Hands Guild.    The Healing Hands Guild was established to honor physicians who excel...

Independent Pharmacy Cooperative to Distribute Promescent, Topical Medication for Premature Ejaculation

HUNTINGTON BEACH, Calif., June 14, 2013 /PRNewswire/ -- The Independent Pharmacy Cooperative (IPC) and Absorption Pharmaceuticals (AP) have signed a distribution agreement whereby IPC will make AP's topical treatment for premature ejaculation, Promescent, available to its 4,500+ member pharmacies throughout the United States. Promescent is fast becoming first-line therapy for premature ejac...

Uroplasty Announces Delay in Filing Form 10-K

MINNEAPOLIS, June 14, 2013 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative products to treat voiding dysfunctions, announced today that it will delay the filing of its Annual Report on Form 10-K for the year ended March 31, 2013, until the completion of a review of its internal control over financial reporting. In con...

New approach for late-stage prostate cancer

(Medical Xpress)—For the past 70 years, androgen deprivation therapy (ADT) has been the standard treatment for men diagnosed with late-stage prostate cancer.

International Adhesions Society Joins Efforts of Interstitial Cystitis Association on Capitol Hill Advocating for Funding to Help Millions of Pain Sufferers

On June 4, 2013, the Interstitial Cystitis Association, an organization advocating for about 12 million Americans with a painful chronic bladder condition, led a group, including the International Adhesions Society, many of whose members suffer from bladder pain, to Capitol Hill to advocate for continued funding of research, education and awareness programs conducted within NIH, CDC and the Depart...

Novel Drug Interferes with Androgen Receptors and Blocks Prostate Cancer Growth

A novel, small molecule peptidomimetic drug called D2 interferes with the function of androgen receptors, blocking the androgen-induced proliferation of...

IOM Standards For Clinical Practice Not Fully Met By Cancer Guidelines

In an age when evidence-based care is increasingly important, how trustworthy are current clinical practice guidelines? Researchers at the University of Michigan Comprehensive Cancer Center looked at 169 cancer clinical practice guidelines for lung,...

PCA3 assay ups predictive accuracy for repeat biopsy

(HealthDay)—For men with at least one prior negative biopsy, urinary PCA3 scores, together with serum prostate-specific antigen and other clinical information, improve the prediction accuracy for repeat biopsy outcome, according to a study publishe...

Amgen’s Xgeva Gains FDA Nod For Use In Rare Bone Tumor

Approval of denosumab for giant cell tumor of the bone comes more than a year after Amgen’s failed bid to add a more commercially significant indication for prevention of bone metastases in patients with castrate-resistant prostate cancer.

Near A 52-Week Low, Is OncoGenex Pharmaceuticals A Buy?

ByC.R. Jackson:Approximately 90% of cancer patients with metastatic breast, prostate, lung or colon cancers develop resistance to chemotherapy. Despite scientific advances, cancer treatment failure due to treatment resistance is a major problem in oncology.OncoGenex Pharmaceuticals Inc. (OGXI) has focused its efforts on the development of therapeutics that target important mechanisms of cancer tre...

Finasteride, medication for male pattern hair loss, may also decrease drinking

Finasteride is a synthetic drug for the treatment of male pattern hair loss (MPHL) and an enlarged prostate. The side effects of finasteride for treatment of these two conditions can include increased rates of sexual dysfunction, such as low libido a...

HeartSine Recruits Athlete Saved by Defibrillator

HeartSine® Technologies (www.heartsine.com), the leading manufacturer of Automated External Defibrillators (AEDs), has recruited an inspirational swimmer who was saved by a defibrillator after experiencing Sudden Cardiac Arrest (SCA). Brian Duffield collapsed at the age of 40 in Tucson, Arizona, after a routine swimming workout in 2006....

UPDATE- ValiRx agrees details of cancer study

ValiRx has agreed an expanded and adaptive protocol for its first-in-man studies on VAL 201, its drug candidate being developed for prostate cancer. This simply means the early-stage study has been tweaked to allow the compound to move more efficient...

Astellas Introduces Option for Men with Advanced Prostate Cancer

Xtandi™ (enzalutamide capsules) is now available in Canada. On May 30, 2013, Health Canada approved Xtandi for the treatment of patients with metastatic castration-resistant prostate cancer, or mCRPC, who have received prior docetaxel therapy (chem...

Theragenics Corporation Extends Exclusivity Period Under Letter Agreement with Juniper Investment Company

Juniper Affirms $2.25-$2.30 Per Share Proposal Theragenics Corporation® (NYSE: TGX), a medical device company serving the surgical products and prostate cancer treatment markets, today announced that, based on ongoing discussions, the Company and Juniper Investment Company, LLC (“Juniper”) have agreed to extend the exclusivity period under the let...

Transvaginal Mesh Lawsuit Filed by Wright & Schulte Alleges that Boston Scientific’s Defective Mesh Sling Caused New York Woman to Suffer Serious, Irreversible Injuries

Columbus, OH (PRWEB) June 13, 2013 Wright & Schulte lawyers have filed a transvaginal mesh lawsuit against the Boston Scientific Corporation on behalf of a woman from New York. This Vaginal Mesh Lawsuit or Bladder Mesh Lawsuit (case no....

Medicare Boosts Coverage for FDG-PET Scans in Cancer

CMS will now cover 3 post-treatment FDG-PET scans in cancer patients and reversed an earlier proposal not to cover prostate cancer. Medscape Medical News

Urine Test Detects Bladder Cancer

A simple urine test has been developed that can detect urothelial carcinoma of the urinary bladder and may greatly improve...

ValiRx makes enhancements to cancer study

ValiRx has agreed an expanded and adaptive protocol for its first-in-man studies on VAL 201, its drug candidate being developed for prostate cancer. This simply means the early-stage study has been tweaked to allow the compound to move more efficient...

Upcoming Father's Day Raises Heart and Prostate Diseases Awareness and Necessity for Thermobalancing Therapy as Effective Solution, States Fine Treatment

Sunday, June 16th is Father’s Day, when it is worth reminding our dads of the importance of taking care of their health, especially of their heart and prostate, as heart disease is the leading cause of death in the USA and prostate conditions are a major health threat exclusive to men. Dr. Allen’s Devices for heart and prostate care are able to treat coronary heart disease, BPH and chronic pro...